Joint Formula
Natural health product licensed in Canada
- Licence holder
- Canadian Phytopharmaceuticals Corporation
- NPN or DIN-HM
- 80055205
- Status
- Active licence
- Licence date
- 28 October 2014
- Revision date
- 8 December 2015
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trichosanthes kirilowii Maxim.: L'absence de trichosanthine doit être prouvée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Clematis terniflora var. mandshurica Source : Racine Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 2,000 mg | 50 mg | Not calculated |
| Prunella vulgaris Source : Tige(s) Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 2,000 mg | 50 mg | Not calculated |
| Prunella vulgaris Source : Fleur Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 2,000 mg | 50 mg | Not calculated |
| Trichosanthes kirilowii Source : Racine Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 4,000 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis and rheumatoid arthritis. A factor in maintaining good cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80055205
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.